Trial Identifier: | D1699R00045 |
Sponsor: | AstraZeneca |
Start Date: | November 2024 |
Primary Completion Date: | December 2026 |
Study Completion Date: | December 2026 |
Condition: | Heart, Blood & Circulatory - Other; Congestive Heart Failure |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.